.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
UBS
Colorcon
Fish and Richardson
Johnson and Johnson
Citi
Chubb
Moodys
Queensland Health
Argus Health

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017789

« Back to Dashboard

NDA 017789 describes AMINOSYN 7% W/ ELECTROLYTES, which is a drug marketed by Icu Medical Inc and is included in one NDA. It is available from one supplier. Additional details are available on the AMINOSYN 7% W/ ELECTROLYTES profile page.

The generic ingredient in AMINOSYN 7% W/ ELECTROLYTES is amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride. There are three hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride profile page.

Summary for 017789

Tradename:3
Applicant:1
Ingredient:4
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 017789

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMINOSYN 3.5% amino acids INJECTABLE;INJECTION 017789 NDA Hospira, Inc. 0409-4196 0409-4196-05 6 POUCH in 1 CASE (0409-4196-05) > 1 BAG in 1 POUCH > 1000 mL in 1 BAG
AMINOSYN 3.5% M amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride INJECTABLE;INJECTION 017789 NDA Hospira, Inc. 0409-4196 0409-4196-05 6 POUCH in 1 CASE (0409-4196-05) > 1 BAG in 1 POUCH > 1000 mL in 1 BAG

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength7%;102MG/100ML;522MG/100ML;410MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3.5%;21MG/100ML;40MG/100ML;128MG/100ML;234MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 004

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3.5% (3.5GM/100ML)
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Moodys
Merck
Healthtrust
Express Scripts
Fish and Richardson
Cantor Fitzgerald
Dow
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot